Children's Health Ireland (CHI)
Supply, implementation and support of PCR-based CFTR variant testing assays
Children's Health Ireland (CHI) has entered into an agreement with Youregene Heath UK Ltd for the supply, implementation, and support of PCR-based CFTR variant testing assays. The assays are intended for genetic testing related to Cystic Fibrosis (CF) and CF-related disorders, including diagnostic confirmation, carrier screening, and newborn screening follow-up. The contract has a duration of 60 months and a final value of 400,000 EUR.